(2009). ABC transporters, drug resistance, and cancer stem cells.
(2010). Bigner DD: MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
(2010). Bigner DD: Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.
(2004). Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy. Cell Mol Immunol
(2009). Dendritic-cell- and peptide-based vaccination strategies for glioma. Neurosurg Rev
(2008). Drug Insight: panitumumab, a human EGFRtargeted monoclonal antibody with promising clinical activity in colorectal cancer. Nat Clin Pract Oncol
(2005). Druker BJ: The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood
(2009). Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma. Cancer Invest
(2008). H: Specificity in cancer immunotherapy. Semin Immunol
(2010). Highdose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma. Haematologica
(2008). ID: P-glycoprotein: so many ways to turn it on.
(2006). IL: The cancer stem cell hypothesis: a work in progress. Lab Invest
(2006). JC: Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin. Cancer Immunol Immunother
(2010). Klar E: Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).
(2000). LD: Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.
(1999). LM: The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity
(2004). Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood
(2007). Markers of chemoradiation resistance in patients with locally advanced head and neck squamous cell carcinoma, treated by intra-arterial carboplatin and concurrent radiation. Acta Otorhinolaryngol Ital
(2009). Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4. Clin Cancer Res
(2007). Melief CJ: Identification of T-cell epitopes for cancer immunotherapy. Leukemia
(1999). MJ: A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example. Mol Diagn